Ana Stojanovska
Ana Stojanovska is a Senior Director who develops and implements reimbursement strategies for pharmaceutical and biotech products. She advises clients on comprehensive pre- and post-launch reimbursement strategies and tactical implementation, from product planning and market assessment to product launch and ongoing policy development.
Ms. Stojanovska has extensive experience working with key stakeholders in motivating local coverage of new products by both public and private payers. She also provides strategic compendia analyses and ongoing coding support. Ms. Stojanovska frequently speaks on reimbursement issues for public and private payers, physicians, and specialty sales representatives. Her therapeutic areas of particular expertise include oncology, urology, rheumatology, and nephrology.
Before joining Xcenda, she worked for a bipartisan, non-profit health policy organization in Washington DC, where her responsibilities included research, health policy analysis, media outreach, and fundraising. Ms. Stojanovska received a Bachelor of Science in biochemistry and a Bachelor of Arts in communications from the University of California, Berkeley.
